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Abstract
Objective: To estimate the prevalence of medication-related incidents in an intensive care unit.
Methods: Cross-sectional study that included 116 records of hospitalizations within a 12-month period. 
The survey instrument was developed based on the study variables and was validated by two experts. The 
prevalence was calculated by considering the number of exposed hospitalizations as the numerator and the 
total of investigated hospitalizations as the denominator, calculating a 95% confidence interval. Fisher’s exact 
test assuming maximum significance level of 5% (p<0.05) was used to verify significant association.
Results: It was observed that 113 hospitalizations had been exposed to at least one type of incident, totaling 
2,869 occurrences: 1,437 reportable circumstances, 1,418 no-harm incidents, 9 near-miss incidents and 5 
adverse events. The incidents occurred during the prescription stage (45.4%) and the absence of information 
on the actions taken by the health professionals in relation to the incidents was identified in 99% of the records.
Conclusion: Prevalence of 97.4% of medication-related incidents was estimated.
Resumo
Objetivo: Estimar a prevalência de incidentes relacionados à medicação em uma Unidade de Terapia Intensiva.
Métodos: Estudo transversal que incluiu 116 registros de internações hospitalares no período de 12 meses. 
O instrumento de pesquisa foi elaborado com base nas variáveis de estudo e validado por dois experts. A 
prevalência foi calculada considerando o número de internações expostas como numerador e o total de 
internações investigadas como denominador, calculando intervalo de confiança de 95%. Para a verificação de 
associação significativa entre as variáveis, utilizou-se o Teste Exato de Fisher, assumindo nível de significância 
máximo de 5% (p<0,05).
Resultados: Verificou-se que 113 internações foram expostas a pelo menos um tipo de incidente, totalizando 
2.869 ocorrências, sendo 1.437 circunstâncias notificáveis, 1.418 incidentes sem dano, nove potenciais 
eventos adversos e cinco eventos adversos. Os incidentes aconteceram durante a fase da prescrição (45,4%) 
e a ausência de conduta dos profissionais de saúde frente aos incidentes foi identificada em 99% dos registros.
Conclusão: Estimou-se prevalência de 97,4% incidentes relacionados à medicação.
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Introduction
Drug therapy is widely used in intensive care units. 
It is used twice as much as in other hospital units 
because of the nature of the care provided and criti-
cal patient profiles requiring complex, urgent inter-
ventions.(1)
Incorrect use and absence of safety standards 
undermine the efficacy of drugs and may cause seri-
ous incidents for patients and health institutions.(2)
Medication-related incidents are circumstances 
or events that may or may not cause unnecessary 
harm to the patient. They are classified as: report-
able circumstances, no-harm incidents, near-miss 
incidents and adverse events.(3,4)
According to international studies, such inci-
dents may affect up to 947 of 1,000 patients per 
day in intensive care units, increasing hospital costs 
up to $2.8 million.(5,6)
In 2009 in Brazil, 305 medication-related in-
cidents were identified in 44 patients hospitalized 
in an intensive care unit evaluated over a period of 
30 days.(7)
In this sense, intensive care units are identified 
as high-risk scenarios for medication-related inci-
dents, whether due to the instability of the clini-
cal condition of the patients or to the variability 
of situations and time pressure to which health 
care professionals are subjected, particularly nurs-
ing staff.(1)
Despite advances in studies about medica-
tion-related incidents, it remains difficult to mea-
sure their extent, characteristics and prevalence, 
hindering coping with and management of risks 
related to drug therapy in intensive care units.(7)
Thus, this study aimed to estimate the preva-
lence of medication-related incidents identified in 
records of patients hospitalized in an intensive care 
unit in a teaching hospital.
Methods
Cross-sectional study conducted in the intensive 
care unit of a tertiary school hospital located in the 
city of Goiânia, central region of Brazil. The insti-
tution is part of the Unified Health System of the 
Brazilian government and has had a risk manage-
ment service since 2002 that encourages reporting 
of incidents.
The population of the study consisted of 116 
records of patients hospitalized in the intensive 
care unit in the period from January 1 to Decem-
ber 31, 2011. All patients who were admitted 
to the unit within the period of the study and 
had made use of drugs during the hospitalization 
period were considered. The research tool was 
structured and pre-validated by two experts in 
patient safety, and included the following vari-
ables: gender, age, duration of hospitalization, 
hospital specialty, clinical outcome, number of 
medications in use, number of doses used, clin-
ical outcome, type of incident, type of problem, 
stage of the process, shift in which the incident 
occurred and behavior of the professional in re-
lation to the incident.
The Conceptual Framework for the Interna-
tional Classification for Patient Safety proposed 
by the World Health Organization was adopted 
to classify the variable “type of incident.” Ac-
cording to this classification, a reportable cir-
cumstance is a situation in which there is signif-
icant potential for harm but no incident occurs; 
a no-harm incident is an event that reaches the 
patient but no harm occurs; a near miss is an 
incident that is intercepted before reaching the 
patient; and an adverse event is an incident that 
results in harm to the patient.(3,4)
Data were descriptively analyzed with the 
Statistical Package for Social Science, version 
22.0 for Windows, presenting absolute and rel-
ative frequencies. The prevalence was calculat-
ed by considering the number of exposed hos-
pitalizations as the numerator and the total of 
investigated hospitalizations as the denominator, 
calculating a 95% confidence interval. Fisher’s 
exact test assuming a maximum significance lev-
el of 5% (p<0.05) was used to verify significant 
association.
The development of the study complied with 
national and international standards of ethics in re-
search involving human beings.
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Results
All 116 hospitalizations that occurred in 2011 
were analyzed. A predominance of female patients 
(52.6%) was observed, and the average age was 56.3 
years. Infectious diseases accounted for 21.5% of 
the admissions in the unit. The mean hospitaliza-
tion period was 10.5 days and the death rate was 
84%. The use of drugs in the unit produced 1,272 
prescription sheets, totaling 30,257 doses prescribed 
during the period of analysis.
The study identified 2,869 incidents in 113 
hospitalizations, an estimated prevalence of 97.4% 
(IC 95%; 93.1 - 99.3%). Reportable circumstances 
were the most prevalent type of incident, at 88.7% 
(IC 95%; 82.0 - 93.6%), followed by no-harm in-
cidents at 87% (IC 95%; 80 - 92.2%), near-misses 
at 6% (IC 95%; 2.6 - 11.5%) and adverse events at 
2.5% (IC 95%; 0.6 - 6.8%).
There were 1,437 cases of reportable circum-
stances registered during the hospitalizations. High-
er occurrence was observed during the prescription 
and record stages, as shown in table 1. Absence of 
administered drug checks was the type of report-
able circumstance that presented higher incidence 
(47.9%), followed by absence of annotations about 
administration of drugs (21.1%). The study also 
demonstrated the practice of early prescription 
(7.7%), which involves inserting a drug into a pre-
scription sheet on a different day of its administra-
tion, thus increasing the risk of inadvertent admin-
istration.
Table 2 describes the 1,418 no-harm incidents 
detected; most were related to the drug prescrip-
tion and administration stages. It emphasizes the 
occurrence of incomplete prescriptions in 62.4% 
of the cases and omission due to lack of drugs in 
the health care institution in 22.3%, indicating 
lack of planning and/or resources to fully assist 
patients.
In relation to the records of near-miss and ad-
verse events, 14 records were found, as described 
in Table 3. Regarding near-miss incidents, it is 
emphasized that interception of extra doses due to 
incorrect scheduling was the most recurrent inci-
dent (88.9%). In relation to adverse events, it was 
observed that 100% were avoidable and occurred 
during the administration stage.
Regarding the time of occurrence of the inci-
dents, it was verified that 69% occurred during the 
daytime. It was also found that only in 1% of occur-
rences did health care professionals report the ther-
apeutic decision shortly after identification of the 
incident. These include: suspension of drug admin-
istration (0.6%), adjustment of the activity (0.3%) 
and additional monitoring (0.1%).
The results obtained in the Fisher’s exact test 
showed that the occurrence of reportable circum-
stance was significantly associated with males 
(p=0.021), hospitalization time of up to 5 days 
(p=0.000) and use of up to 20.9 doses per day 
(p=0.015). No-harm and near-miss incidents pre-
sented associations with length of hospitalization 
of up to 5 days (p=0.003). No significant associa-
tion between the variables was verified for adverse 
events.
Table 1. Reportable circumstances
Type of problem n(%)
Absence of administered drug check 689(47.9)
Absence of annotation about drug administration 303(21.1)
Prescription with time duplication 256(17.8)
Early prescription 111(7.7)
Verbal drug suspension 40(2.8)
Lack of equipment to administer drugs (masks, expanders and others) 24(1.7)
Prescription with impaired print 11(0.8)
Prescription with drug duplication 2(0.1)
Prescription in improper form 1(0.1)
Total 1,437(100)
Table 2. No harm incidents
Type of problem n(%)
Incomplete prescription (missing dose, route, interval and/or other information) 883(62.4)
Omission by lack of drug in the institution 316(22.3)
Failure in dose scheduling and intervals 121(8.4)
Prescription of non-standard drugs 30(2.1)
Lapses, misconceptions and/or failures in dispensation 21(1.5)
Omission by patient out of the unit 9(0.6)
Unauthorized administration: Suspension of drug without notifying the nursing staff 9(0.7)
Extra dose due to early prescription 7(0.5)
Illegible drug name 5(0.4)
Omission resulting from lack of device to administer the drug 5(0.4)
Delay in administration schedule 5(0.4)
Anticipation in administration schedule 3(0.2)
Prescription to patient that is known to be allergic 2(0.1)
Pharmacy refused to accept the request 1(0)
Extra dose due to duplicate prescription 1(0)
Total 1,418(100)
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Discussion
The present study has limitations in relation to the 
method that should be considered in the interpre-
tation of the results. As such situations could result 
in penalties, the possibility of omission of some re-
cords of incidents and their consequences to pro-
fessionals is considered. In addition, the review of 
retrospective data in secondary sources must also be 
considered in view of the quality of hospital records 
in Brazil.
However, the study provides deeper insight into 
the problem of medication-related incidents in in-
tensive care units, contributing to review of work 
processes and supporting the development and im-
plementation of preventive actions targeting the 
quality and safety of patient assistance.
The first finding of this study was that the death 
rate in the investigated scenario was extremely high, 
surpassing findings of an international multicenter 
survey.(8) The high death rate was related to the pa-
tient profiles, which were severe, with several co-
morbidities and multiple concurrent clinical prob-
lems.(9) Combined with this, Brazil presents con-
stant unavailability of beds in intensive care units, 
which hinders access by patients and affects the sur-
vival rate and therapeutic possibilities.(10)
The findings on reportable circumstances in this 
study provide knowledge about another dimension 
of medication-related incidents in intensive care 
units, in which the events are inserted into the ev-
eryday context of the structure and work processes 
of the unit. In this sense, several publications pre-
sented satisfactory results in patient safety resulting 
from redesign of work processes and involvement of 
healthcare professionals.(11,12)
It was observed that medication-related inci-
dents were common in intensive care units. And 
although a very small fraction caused harm to pa-
tients, it is still necessary to manage the risks related 
to the medication process, considering that critical 
patients present higher needs for care and are there-
fore more vulnerable.(13)
It was also found that near-miss incidents 
showed low prevalence. However, at the same that 
they demonstrate failures in carrying out activities, 
they also show the human capacity to intercept 
incidents. Most of the near-miss incidents were 
related to the administration stage, especially in-
volving the interception of additional doses and 
the prescription of drugs to patients known to be 
allergic.
The results contribute to the capacity of nurs-
ing teams to intercept medication-related incidents, 
which constitute a major barrier to patient safety.
(14,15) However, the low number of records of near-
miss incidents suggests the need to encourage and 
improve this capacity in light of the constitution 
of this defense barrier to patient safety in intensive 
care units. As nursing team professionals essentially 
work in the final stage of drug therapy, their respon-
sibility for identifying and preventing such failures 
increases, as the administration act may interrupt 
the system and prevent mistakes initiated in early 
stages.
Adverse events presented a prevalence of 2.5%, 
and all the cases were related to the administra-
tion stage; most were generated by dose omission 
and adverse reactions to medications. These results 
significantly diverged from other national and in-
ternational research.(5,16) This difference suggests 
underreporting that masks the true magnitude of 
the events and undermines the quality of the care 
provided, also revealing a possible aspect of the or-
ganizational culture of institutions, as only 1% of 
the records described the actions of professionals in 
cases of incidents.
In many cases, reporting is seen as a rendering 
of accounts, which is also a barrier to voluntary re-
porting.(17) Understanding safety in the medication 
process in a punitive way contributes neither to the 
development of assertive care practices nor to the 
Table 3. Near-miss and adverse events
Variables n(%)
Near-miss incidents
Prescription to patient that is known to be allergic 1(11.1)
Additional dose due to incorrect scheduling 8(88.9)
Total 9(100)
Adverse events
Hypertension by dose omission 2(40)
Adverse reaction to drug 3(60)
Total 5(100)
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development of institutional safety culture in orga-
nizations.
Safety culture expresses individual and collec-
tive values, attitudes, skills and behavior patterns 
that determine the commitment and proficiency 
of safety and health programs in organizations. 
When organizations can build positive safety cul-
ture, they attain better levels of communication, 
common perceptions of the importance of safety, 
and confidence in the effectiveness of preventive 
actions.(18)
The prescription stage had a higher proportion 
of incidents, similar to results found in other in-
ternational research. Incidents in this stage of the 
medication process are common and must be con-
fronted by professionals and health managers, es-
pecially in teaching hospitals, where safety culture 
- if implemented during the formation of health 
professionals - may result in changes in the health 
system.(6)
Daytime was the period that presented a higher 
number of occurrences, similar to findings by na-
tional studies in intensive care units. This is related 
to the proportionally higher volume of drugs ad-
ministered during this period.(6,7)
It was observed that occurrences of medica-
tion-related incidents were associated with peri-
ods of hospitalization above 5 days, male patients 
and daily use of multiple doses of drugs. There is 
a consensus in several studies that prolonged hos-
pital stays increase the exposure of patients to risks 
of being affected by incidents or failures during the 
care process and to the several environmental and 
intrinsic factors of a hospital environment.(19,20)
The administration of large amounts of drugs 
per day may confuse health professionals and 
lead to incidents, as observed in an internation-
al study.(21) However, the findings of that study 
suggested that other variables should also be con-
sidered, given that the prevalence of incidents was 
inversely proportional to the number of doses per 
day. These considerations reinforce the fact that 
the success of drug therapy in intensive care units 
involves conscious multidisciplinary work, appro-
priate staff assignments and a systemic approach 
to failures.(22)
Conclusion
The study identified 2,869 medication-related in-
cidents, with prevalence of 97.4% of exposed hos-
pitalizations. Of these, 45.5% was related to the 
prescription stage and 99% of the records did not 
present the actions of the health professionals in re-
lation to the incidents.
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